Heart Diseases in Down Syndrome by Rashid, A. K. M. Mamunur
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 6
Heart Diseases in Down Syndrome
A. K. M. Mamunur Rashid
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/46009
1. Introduction
Down  syndrome  (trisomy  21)  is  the  common  disorder  among  chromosomal  anomalies.
Trisomy 21 remains the commonest with its incidence 1:650 – 1: 1000 live births (Hassold
TA and Sherman S 2000). The clinical manifestations of Down syndrome (DS) are numer‐
ous and can present in any body system. The most significant include intellectual impair‐
ment,  short  stature,  heart  disease,  digestive  disorders  and  orthopedic  abnormalities
(Ramakrishnan V, 2011).
Cardiac malformations present at birth are an important component of pediatric cardiovas‐
cular disease and contribute a major percentage of clinically significant birth defects with an
estimated prevalence of 4 to 5 per 1000 live births. It is estimated that 4 to 10 live born in‐
fants per 1000 have cardiac malformation, 40% of which are diagnosed in the first year of
life.(Hoffman J I, 1990 ; Moller J H et al, 1993). Congenital heart defect are the most common
of all birth defects, which is found to affect nearly 1% of newborns, and their frequency in
spontaneously aborted pregnancies is estimated to be tenfold higher (Behrman RE et al.,
2000). In the year 2000, prevalence of CHD in the pediatric population was estimated at ap‐
proximately 623000 (320000 with single lesion, 165000 with moderately complex disease,
and 138000 with highly complex CHD). (Hoffman J I et al, 2004) Among the CHD the inci‐
dence of ventricular septal defect (VSD) has been demonstrated to be high as 5% in 2 inde‐
pendent cohorts of 5000 serial newborns, 5000 serial premature infants. (Roguin N et al.,
1995; Du Z D et al., 1996)
The causes for CHD can be categorized in to three major groups such as chromosomal, sin‐
gle gene disorder (10-15%) and multiple factors (85-90%). (Payne M et al., 1995)
Its association of congenital heart disease is well known. Among all cases of congenital heart
diseases, 4%-10% are associated with Down syndrome, and 40%-60% of Down syndrome
patients present congenital heart disease. Cardiac malformation in DS is the principal cause
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of mortality in the first two years of life. (Rodriguez LH, 1984; Stoll C, et al., 1998) This con‐
genital heart disease contributes significantly to the morbidity and mortality of children
with Down syndrome, who may develop congestive heart failure, pulmonary vascular dis‐
ease, pneumonia, or failure to thrive. In the first few days life symptoms or signs may be
absent or minimal despite the presence of significant congenital heart disease. The character‐
istic heart defects seen in Down syndrome derives from the abnormal development of endo‐
cardial cushions and results in a spectrum of defects involving the atrioventricular septum
and valves. Accounting for approximately 63% of all DS-CHD, their lesion varies in severity
from persistent of the common atrioventricular canal and membranous ventricular septal
defects to ostiumprimum patency with valvular anomalies. (Cooney T P et al., 1982; Ander‐
son R H, 1991) The specificity of atriventricularseptal defects for trisomy 21 is emphasized
by the observation that individuals with Down syndrome account for 70% of all atriventri‐
cularseptal defects. (Ferencz C et al.,1997) This is followed by patent ductus arteriosus and
atrial septal defects. Other forms of complex heart disease can occur including overriding
aorta and Tetralogy of fallot. (Berr C and Borghi E, 1990) The hypothesis suggests the exis‐
tence of a gene or gene clusters on chromosome 21 which is involved in cell adhesion and
likely plays an important role in valvuloseptal morphogenesis, but when over expressed, re‐
sult in the defects of Down syndrome – congenital heart disease. (Barlow G M et al., 2001)
2. Etiology and genetics
Down syndrome which is normally caused by trisomy 21 is a major cause of congenital
heart  disease  and  provides  an  important  model  with  which  to  link  individual  to  the
pathways  controlling  heart  development.  The  characteristic  heart  defect  seen  in  Down
syndrome derives  from the  abnormal  development  of  the  endocardial  cushions  and re‐
sults  in a spectrum of defects  involving atrioventricular septum and valves.  Accounting
for approximately 63% of all DS-CHD,( Van PR et al., 1996) these lesions vary in severity
from persistence of the common atrioventricular canal and membranous ventricular sep‐
tal defects to Ostium primum patency with valvular anomalies.  (Cooney TP et al.,  1982;
Anderson RH, 1991)  Independent and intersecting approaches to identifying the gene(s)
for  DS-CHD  have  included  mapping  genes  known  to  be  involved  in  cardiac  develop‐
ment  (none  of  which  localized  to  chromosome  21)  and  studying  rare  individuals  with
CHD and partial duplications of chromosome 21. There are number of genetic tests that
can assist the clinician in diagnosing genetic alterations in the child with CHD. These in‐
clude  cytogenetic  technique,  fluorescence  in  situ  hybridization  (FISH),  and  DNA muta‐
tion analysis.(Pierpont ME et al., 2007) The studies initially suggested that subsets of the
DS phenotype were associated with three copies of  chromosome band 21q22.2-22.3(Rah‐
mani Z et al., 1989; McCormick MK et al., 1989; Korenberg JR et al., 1990) and later, that
DS-CHD  was  caused  by  the  over  expression  of  genes  in  the  region  including  D21S55
through the  telomere.(Korenberg  JR  etal.,  1992;  Delabar  JM et  al.,1993;  Korenberg  JR  et
al., 1994) Another work focused on the identification of a transcriptional map of DS-CHD
region using a 3.5 Mb contiguous clone array covering the interval from D21S55 through
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MX1/2.(Hubert RS et al.,  1997) Recent study speculate that the over expression of Down
syndrome cell adhesion molecule may have the potential to perturb epithelial-mesenchy‐
mal  transformation  and/or  the  migration  and  proliferation  of  mesenchymal  cells,  and
possibly thus contribute to the increased intercellular adhesion seen in DS cushion fibro‐
blasts  and  abnormal  cushion  development  seen  in  DS-CHD.  The  DSCAM  gene  consti‐
tutes  a  large  part  of  the  DS-CHD  region,  spanning  more  than  840Kb  of  the  region
between D21S3 and (PFKL) as determined from BAC contigs (Yamakawa K et al.,  1998)
and genomic sequence analysis.( Hattori M et al., 2000) The study for DS-CHD suggests
that  the  candidate  region  for  DS-CHD  may  be  narrowed  to  D21S3  (Defined  by  VSD),
through PFKL (defined by TOF), comprising 5.5 Mb. This represents significant reduction
of the previously described candidate region, which spanned 10.5 Mb from D21S55 to the
telomere.  (Korenberg JR et  al.,  1992;  Korenberg JR et  al.,  1994)  This  study supports  the
hypothesis  that  trisomy for  a  gene in  the DS-CHD candidate  region is  essential  for  the
production of DS-CHD including TOF and VSD, trisomy for additional genes located in
the telomere and other regions likely contributes the phenotypic variability of  DS-CHD.
(Barlow GM et al., 2001)
3. Type of heart defects in children with Down syndrome
• Atrioventricular septal defects (AVSDs)- These are the most common in children with
Down syndrome.
• Atrial Septal Defects (ASDs)
• Patent Ductus arteriosus (PDA)
• Tetralogy of Fallot (TOF)
In a study by TRJ Tubman & et al. among 34 babies of Down syndrome had congenital heart
disease detected by echocardiography (13 had atrioventricularseptal defects, seven secen‐
dum atrial septal defects, six solitary patent ductusarteriosus, five isolated ventricular septal
defects, and three combinations of heart defects.)(Tubman TRJ et al., 1991)
Another study showed the association between CHD and DS in atrioventricularseptal defect
56 (35%), ventricular septal defect 48 (30%),ASD 14 (8.7%), TOF 8(5%), PDA 18 (11.2%) and
other heart defects 20(12.5%). (Ramakrishnan, V. 2011)
4. Presentations
4.1. Atroventricular Septal Defects (AVSDs)
These heart defects are marked by a hole in the wall between the top chambers (atria) and
bottom chambers (ventricles) and one common valve between the two atria. In some cases,
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there might not be a hole between the bottom chambers. Or the valves may be joined togeth‐
er, but either or both might leak.
Because of the high pressure in the left ventricle which is needed to pump the blood around
the body, blood is forced through the holes in the central heart wall (septum) when the ven‐
tricles contracts. This increases the pressure in the right ventricles. This increased pressure
(pulmonary hypertension) results in excess blood flow to the lung.
Some of the early symptoms seen are difficulty in eating, weight gain, fast irregular breath‐
ing and a degree of cyanosis (blueness) particularly noticeable around the mouth, fingers
and toes. Clinical examination may show an enlarged heart and liver, and a diagnosis of
heart failure may be given. This term, not all children will exhibit symptoms early in life,
and those that do will not always show all of these features.
4.2. Ventricular Septal Defects (VSDs)
In this defect there is a hole between the bottom clambers (pumping chambers or ventricles).
Because of the higher pressure in the left side of the heart this allows oxygenated blood to
flow through the hole from the left to the right side of the heart and back to the lungs in
addition to the normal flow. The amount of blood flow from the left to right ventricle de‐
pends on the size of the hole and on the pressure between the ventricles. In other words, the
higher the rate of flow means more strain on the heart. The abnormal blood flow is responsi‐
ble for the murmur that may be heard.
Generally patients with a small VSD will not exhibit symptoms (they are asymptomatic) and
the problem may only be found when a murmur is detected upon routine examination. Pa‐
tients with a moderate VSD may breathe quickly, exhibit poor weight gain and be slower at
eating. These children are also much more prone to chest infection. This tends to be more
pronounced when the hole is large.
4.3. Atrial Septal Defects (ASDs)
In this defect there is a hole between the top chambers (receiving chambers or atria). Because
of the higher pressure in the left side of the heart, oxygenated blood flows through the hole
from the left to the right side, and back to the lungs, in addition to the normal flow.
There are three types of atrial septal defects; the most common is when there is a hole in the
middle of the central heart wall. Holes in the lower part of the septum, called primum defect
(partial atrioventricularseptal defect), are often associated with a problem of the mitral valve
that often results in a leak. Less common are sinus venosus defects or holes in the top of the
septum. These are associated with an abnormality of the right upper lung vein.
Generally patients with an ASD defect will exhibit no symptoms and the problem is only
found when a routine clinical examination detects a heart murmur. Occasionally children
with this problem will exhibit poor weight gain and a failure to thrive, and if there is mitral
valve leakage there may be early symptoms of breathlessness.
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4.4. Patent Ductus Anteriosus (PDA)
This defect is the continuance of a direct connection between the aorta and the lung (pulmo‐
nary) artery, which normally closes shortly after birth. A baby in the womb is supplied oxy‐
gen by the placenta via the umbilical cord. The baby’s lungs are not expanded and require
only a small amount blood for them to grow. The ductus is a blood vessel that allows blood
to bypass the baby’s lungs.
If the ductus has partially closed and only a narrow connection remains, the baby won’t
show symptoms. If the connection is larger, the baby may be breathless and tired and show
poor weight gain.
4.5. Tetralogy of fallot
A small percentage of babies with Down syndrome have this complex heart condition which
combines the most common defect associated with Down syndrome, AVSD, with Tetralogy
of fallot.
This anomaly includes four different heart problems:
• A hole between the top chambers and a hole between the bottom chambers
• Combined mitral and tricuspid valves (common atrioventricular valve)
• Narrowed pulmonary artery (from heart to lungs) or the area under or above the valve, or
all three
• Thickening of the right bottom chamber (ventricle)
The combination of these defects early in life almost seems to balance out such that the child
may be rather blue, but not too breathless. There can, of course, be too much blueness or too
much breathlessness, depending on the severity of the different conditions.
In Tetralogy of fallot (TOF), often caynosis is not present at birth but increasing hypertrophy
of the right ventricular infundibulum and cyanosis occur usually in the later part of infancy.
But cyanosis is present since birth if Tetralogy of Fallot is accompanied with Down Syn‐
drome. This may be due to increased hypertrophy of the right ventricular infundibulum in
patient of TOF with DS at birth. (AKMM Rashid et al., 2009)
5. Case
A case of eleven months boy was admitted in a hospital with the complaints of bluish dis‐
coloration of lip and finger since birth and low grade fever, cough for seven days. Bluish
discoloration aggravates during crying. He was born to an elderly mother and was com‐
pletely immunized. There was no such illness in the family. On examination the child was
cyanosed, heart rate 130/m, weight 7.5 kg. He had got mongoloid face with flat occiput, de‐
pressed nasal bridge, upward slanting of eyes, medial epicanthic fold. There was gap be‐
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tween the first and second toes with clinodactyly. On examination of the precordium there
was left parasternal heave, pansystolic murmur was present in the lower sternal border.
There was motor developmental delay. The boy was clinically diagnosed with congenital cy‐
anotic heart disease with Down syndrome. On investigation his hemoglobin was 78%, Total
leucocyte count 14700/cum, Neutrophil 82%, X – Ray chest had the feature of boot shaped
cardiac shadow. ECG showed right ventricular hypertrophy. Karyotyping showed trisomy
21. Tetralogy of fallot was detected by Echocardiogram. Finally the child was diagnosed as
Down Syndrome with Tetralogy of Fallot. (AKMM Rashid et al., 2009)
Figure 1. Patient with Down syndrome.
Figure 2. Echocardiogram showing Tetralogy of Fallot.
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Figure 3. X-ray chest showing : boot shaped heart.
6. Other heart related problems in Down syndrome
In addition to the heart defects associated with Down syndrome, high blood pressure in the
lungs (pulmonary hypertension) is more common in people with Down syndrome. This
high blood pressure may be a result of malformation of the lung tissue, but the exact cause
is not known. High blood pressure may limit the amount of blood flow to the lungs and
therefore decrease the likelihood of symptoms of congestive heart failure seen in babies with
complete AV canals or large ventricular septal defects.
7. Diagnosis
All babies that have been diagnosed with Down syndrome should have a cardiology evalua‐
tion because of the high incidence of associated congenital heart defects. A good history and
physical examination should be performed in all Down syndrome children to rule out any
obvious heart defect. Early diagnosis of congenital heart disease particularly of large left to
right shunts, could enable a paediatrician to follow the baby carefully, to start medical treat‐
ment with diuretics and digoxin at an earlier stage and possibly to plan for earlier surgical
intervention should this be indicated. Babies should be seen as early in life as possible, pref‐
erably in the first six months of life before pulmonary vascular disease can develop.
Electocardiogram can be very helpful in making the diagnosis of AV canal defect, even in
the absence of physical findings.(Shashi V et al., 2002)
Echocardiography has to be performed routinely early in life in Down syndrome can detect
congenital heart disease that might otherwise be missed. Early detection may help prevent
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complications such as pulmonary vascular disease that may adversely affect the outcome of
cardiac surgery.
Occasionally a repeat electrocardiogram, chest x-ray, or echocardiogram is performed to fur‐
ther evaluate clinical changes. These tests are likely to be repeated before surgical repair is
recommended.
Rarely, a cardiac catheterization is required for complete evaluation prior to corrective sur‐
gery especially in patients where elevated pressures in the lungs are a concern.
8. Treatment
Children with Down syndrome and symptoms of congestive heart failure can be initially
managed medically with the use of diuretics, blood pressure medications to allow the heart
to eject more blood out to the body rather than out to the lungs; and/or digoxin, a medica‐
tion and to improve the pumping ability of the heart.
If the baby is having difficulty with feeding and weight gain, nasogastric tube feeding with
calorie formula or fortified breast milk can be used to help with growth.
These are all temporary solutions to allow the baby to grow while deciding if and when
surgery is  indicated.  If  the baby has no signs of  heart  failure or is  controlled well  with
medications, the decisions for surgical closure can be delayed. The decision must be indi‐
vidualized to each child’s physical state as well as the family’s concerns. The majority of
cases of AVSD usually require surgical intervention; this generally takes place within the
first six months of life.
Many VSD, will close spontaneously or get much smaller, so, it is normal practice to leave a
child with a small or moderate VSD and monitor their progress before deciding to operate.
Surgery may be needed if there is failure to thrive despite medication, or concern about pul‐
monary hypertension. If a large VSD is present, surgery is almost always recommended.
Small holes in ASD which allows little blood flow from left to right generally causes no
problems. If they are located in the middle portion of the central heart wall, they may even
close on their own. However, moderate and large holes do not close, and the extra work
over the years places a strain of the right side of the heart causing an enlargement of both
pumping chambers. Therefore, Surgery is recommended in the first few years of life or larg‐
er holes, before excessive strain has been placed on the heart.
If the ductus open for more than three months, it is unlikely to close on its own and surgical
closure is imperative.
The types of surgery in TOF depend on the severity of the AVSD or the Fallots. Usually the
children are quite blue and require a BT shunt to increase the amount of blue going to the
lungs. Then another operation is performed later- usually at 1-2 years of age- so, that the
holes can be closed, the valves repaired and the way out to the lung artery widened. (Cin‐
cinnati Children’s hospital medical Center, 2006)
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9. Long-term outlook
Over all, survival beyond one year of age is 85 percent in all children with Down syndrome.
Over 50 percent of individuals with Down syndrome live to be greater than 50 years of age.
Congenital heart disease is the most common causes of death in early childhood. However,
as of the late 1980s, 70 percent of children with Down syndrome and congenital heart dis‐
ease lived beyond their first birth day with improved medical and surgical care, these num‐
bers continue to improve. (Cincinnati Children’s hospital medical Center, 2009)
Abbreviation
ASD – Atrial Septal Defect
AVSD- Atrioventricular Septal Defect
BAC- Beta-site APP –Cleaving
CHD- Congenital Heart Disease
DSCAM- Down syndrome cell adhesion molecule
DS- Down syndrome
MX- Myxovirus resistance
PDA- Patent Ductus Arteriosus
PFKL- Phosphofructo-kinase liver types
TOF- Tetralogy of fallot
VSD-Ventricular Septal defect
BT- Blalock Taussig
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